FDA Approves the First New Schizophrenia Drug in Decades
The medicine works in an entirely different way from existing treatments.
FDA approves new schizophrenia drug
Sept. 26 (UPI) -- The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia. 
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia. 
FDA Approves Schizophrenia Drug Cobenfy, the First in Decades
The FDA has approved a schizophrenia drug which is the first updated treatment for the illness in several decades.
New schizophrenia drug ‘could change the lives of millions of people’
A groundbreaking new drug to treat schizophrenia called Cobenfy, owned by pharmaceutical firm Bristol Myers Squibb, has been approved in the US and it is claimed it could change the lives of millions
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Bristol Myers Squibb shares rose Friday, a day after its schizophrenia drug was approved for use by the Food and Drug Administration.
Scientists say new schizophrenia drug could 'change the lives of millions of people'
The US Food and Drug Administration (FDA) has approved the new drug Cobenfy
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
last updated on 28 Sep 00:24